Dashboard
Manage Tickers

TPTXTurning Point Therapeutics,...

Nasdaq www.tptherapeutics.com


$ 76.01 $ 0.52 (0.69 %)    

Tuesday, 16-Aug-2022 16:02:15 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 435.98 $ 8.58 (2.01 %)
DIA $ 386.87 $ 4.54 (1.19 %)
SPY $ 511.25 $ 6.26 (1.24 %)
TLT $ 89.88 $ 0.90 (1.01 %)
GLD $ 212.97 $ -0.17 (-0.08 %)
$ 76.01
$ 75.99 x 500
$ 76.03 x 1,000
-- - --
$ 23.77 - $ 82.20
2,843,392
na
3.78B
$ 1.07
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-08-2022 06-30-2022 10-Q
2 05-10-2022 03-31-2022 10-Q
3 02-28-2022 12-31-2021 10-K
4 11-09-2021 09-30-2021 10-Q
5 08-09-2021 06-30-2021 10-Q
6 05-05-2021 03-31-2021 10-Q
7 03-01-2021 12-31-2020 10-K
8 11-12-2020 09-30-2020 10-Q
9 08-10-2020 06-30-2020 10-Q
10 05-12-2020 03-31-2020 10-Q
11 03-18-2020 12-31-2019 10-K
12 11-04-2019 09-30-2019 10-Q
13 08-06-2019 06-30-2019 10-Q
14 05-31-2019 03-31-2019 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles
Bristol Myers Squibb And Turning Point The...
08/16/2022 11:00:07

Bristol Myers Squibb (NYSE:BMY) and Turning Point Therapeutics, Inc. (NASDAQ:TPTX) ("Turning Point") today announced th...

recap-of-wednesdays-biotech-catalysts---end-of-the-day-summary
Recap of Wednesday's Biotech Catalysts - E...
07/27/2022 23:00:37

turning-point-secures-positive-fda-feedback-for-planned-lung-cancer-drug-submission
Turning Point Secures Positive FDA Feedbac...
07/27/2022 20:45:12

Turning Point Therapeutics (NASDAQ: TPTX) has received positive feedback from the U.S. Food and Drug Administration (FDA) at a ...

turning-point-therapeutics-provides-regulatory-update-for-repotrectinib-for-the-treatment-of-ros1-advanced-nsclc
Turning Point Therapeutics Provides Regula...
07/27/2022 20:22:32

Turning Point Therapeutics, Inc. (NASDAQ:TPTX), a clinical-stage precision oncology company designing and developing novel targ...

Core News & Articles
Bristol Myers Squibb Announces Extension o...
07/19/2022 10:59:45

Bristol Myers Squibb (NYSE:BMY) today has announced that Rhumba Merger Sub Inc. ("Offeror"), a wholly owned subsidiary ...

turning-point-therapeutics-and-md-anderson-announce-strategic-alliance-to-advance-precision-cancer-therapies
Turning Point Therapeutics And MD Anderson...
06/24/2022 13:02:10

Turning Point Therapeutics, Inc. (NASDAQ:TPTX), a clinical-stage precision oncology company designing and developing novel targ...

benzingas-top-ratings-upgrades-downgrades-for-june-13-2022
Benzinga's Top Ratings Upgrades, Downgrade...
06/13/2022 15:05:42

Upgrades

svb-leerink-downgrades-turning-point-to-market-perform-lowers-price-target-to-76
SVB Leerink Downgrades Turning Point to Ma...
06/13/2022 12:07:29

SVB Leerink analyst Andrew Berens downgrades Turning Point (NASDAQ:TPTX) from Outperform to Market Perform and lowers the pr...

benzingas-top-ratings-upgrades-downgrades-for-june-6-2022
Benzinga's Top Ratings Upgrades, Downgrade...
06/06/2022 15:12:03

Upgrades

merger-arbitrage-mondays--bristol-myers-bmy-acquires-third-point-therapeutics-tptx
Merger Arbitrage Mondays – Bristol Myers (...
06/06/2022 15:09:44

Another week and another deal with big pharma buying out a development stage oncology company. Given the real synergies to be h...

analyst-ratings-for-turning-point
Analyst Ratings for Turning Point
06/06/2022 13:08:48

Within the last quarter, Turning Point (NASDAQ:TPTX) has observed the following analyst ratings:

10-biggest-price-target-changes-for-monday
10 Biggest Price Target Changes For Monday
06/06/2022 11:45:46

Citigroup cut PVH Corp. (NYSE: PVH) price target from $94 to $73. PVH shares fell 0.7% to close at $71.96 on Friday.

cowen--co-downgrades-turning-point-to-market-perform
Cowen & Co. Downgrades Turning Point to Ma...
06/06/2022 10:38:49

Cowen & Co. analyst Tyler Van Buren downgrades Turning Point (NASDAQ:TPTX) from Outperform to Market Perform.

hc-wainwright--co-downgrades-turning-point-to-neutral-lowers-price-target-to-76
HC Wainwright & Co. Downgrades Turning Poi...
06/06/2022 10:21:18

HC Wainwright & Co. analyst Robert Burns downgrades Turning Point (NASDAQ:TPTX) from Buy to Neutral and lowers the price...

69-biggest-movers-from-friday
69 Biggest Movers From Friday
06/06/2022 09:31:12

Gainers Turning Point Therapeutics, Inc. (NASDAQ: TPTX) shares climbed 118.4% to close at $74.59 on Friday after Bristol My...

the-week-ahead-in-biotech-june-5-11-adcom-test-for-novavax-asco-presentations-enzo-biochem-earnings-and-more
The Week Ahead In Biotech (June 5-11): Adc...
06/05/2022 20:09:22

Biotech stocks reversed course along with the broader market and closed the week ending June 3 lower. The sector's lean run...

mid-afternoon-market-update-gold-drops-1-sprague-resources-shares-spike-higher
Mid-Afternoon Market Update: Gold Drops 1%...
06/03/2022 18:31:00

U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite dropping more than 300 points on Friday.

12-health-care-stocks-moving-in-fridays-intraday-session
12 Health Care Stocks Moving In Friday's I...
06/03/2022 18:10:40

 

mid-day-market-update-nasdaq-down-300-points-turning-point-therapeutics-shares-jump
Mid-Day Market Update: Nasdaq Down 300 Poi...
06/03/2022 16:08:31

U.S. stocks extended losses midway through trading, with the Nasdaq Composite dropping more than 300 points on Friday.

40-stocks-moving-in-fridays-mid-day-session
40 Stocks Moving In Friday's Mid-Day Session
06/03/2022 16:07:35

 Gainers Turning Point Therapeutics, Inc. (NASDAQ: TPTX) shares jumped 115.8% to $73.72 after Bristol Myers Squibb announced ...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION